Evidence map›Paper›PMID 36227107›Full record

ArticleMicrobiology spectrum2022

Altered Gut Microbial Profile Accompanied by Abnormal Fatty Acid Metabolism Activity Exacerbates Endometrial Cancer Progression.

Shan-Shan Zhao, Lei Chen, Jing Yang, Zhen-Hua Wu, Xiao-Yu Wang, Qi Zhang, Wen-Jie Liu, Hui-Xin Liu

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Shaoyao Gancao decoction alleviates functional constipation by inhibitingFrontiers in cellular and infection microbiology · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Shan-Shan Zhao *Health Sciences Institute, China Medical Universitygrid.254145.3, Shenyang, Liaoning Province, People's Republic of China.
Lei Chen *Health Sciences Institute, China Medical Universitygrid.254145.3, Shenyang, Liaoning Province, People's Republic of China.
Jing YangHealth Sciences Institute, China Medical Universitygrid.254145.3, Shenyang, Liaoning Province, People's Republic of China.
Zhen-Hua WuHealth Sciences Institute, China Medical Universitygrid.254145.3, Shenyang, Liaoning Province, People's Republic of China.
Xiao-Yu WangHealth Sciences Institute, China Medical Universitygrid.254145.3, Shenyang, Liaoning Province, People's Republic of China.
Qi ZhangHealth Sciences Institute, China Medical Universitygrid.254145.3, Shenyang, Liaoning Province, People's Republic of China.
Wen-Jie LiuHealth Sciences Institute, China Medical Universitygrid.254145.3, Shenyang, Liaoning Province, People's Republic of China.
Hui-Xin LiuHealth Sciences Institute, China Medical Universitygrid.254145.3, Shenyang, Liaoning Province, People's Republic of China.ORCID 0000-0002-8981-9981
Jinzhou Medical University · CNLiaoning Cancer Hospital & Institute · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endometrial cancer (EC) is the most prevalent gynecological malignancy, with a higher risk in obese woman, indicating the possibility of gut microbiota involvement in EC progression. However, no direct evidence of a relationship between EC and gut microbiota in humans has been discovered. Here, we performed 16S rRNA sequencing to explore the relationship between dysbiosis of gut microbiota and cancer development in different types of EC patients. The results clearly show the differential profiles of gut microbiota between EC patients and normal participants as well as the association between gut microbiota and EC progression. Targeted metabolomics of plasma revealed an increased level of C16:1 and C20:2, which was positively associated with the abundance of

Indexed as

Endometrial NeoplasmsGastrointestinal MicrobiomeBiomarkersFatty AcidsFecesFemaleHumansIndole AlkaloidsObesityRNA, Ribosomal, 16STOR Serine-Threonine KinasesTumor MicroenvironmentBiomarkersFatty AcidsIndole AlkaloidsRNA, Ribosomal, 16STOR Serine-Threonine Kinasesbiomarkerdysbiosishost-microbe relationshipsmetabolic syndromemicroorganismsobesitytumor microenvironment

Identifiers

PMID36227107
PMCPMC9769730
OpenAlexW4304976106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.